seed
Stage
3
Investors
About
Protai is a biotechnology company that uses mass-spectrometry based proteomics combined with machine learning to identify and model protein complexes as therapeutic targets. Its platform integrates structural proteomics data and AI to support target identification and small-molecule drug discovery.
Explore Protai's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.